ProShare Advisors’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,462
Closed -$810K 1875
2023
Q1
$810K Sell
3,462
-171
-5% -$43.2K ﹤0.01% 759
2022
Q4
$915K Buy
3,633
+521
+17% +$111K ﹤0.01% 757
2022
Q3
$551K Buy
3,112
+55
+2% +$11.1K ﹤0.01% 879
2022
Q2
$558K Sell
3,057
-1,985
-39% -$396K ﹤0.01% 900
2022
Q1
$1.29M Sell
5,042
-835
-14% -$191K ﹤0.01% 825
2021
Q4
$1.35M Buy
5,877
+2,430
+70% +$593K ﹤0.01% 891
2021
Q3
$803K Sell
3,447
-3,530
-51% -$737K ﹤0.01% 986
2021
Q2
$1.35M Sell
6,977
-19
-0.3% -$3.77K ﹤0.01% 873
2021
Q1
$1.45M Buy
6,996
+1,195
+21% +$254K ﹤0.01% 811
2020
Q4
$1.09M Buy
5,801
+2,589
+81% +$423K ﹤0.01% 841
2020
Q3
$415K Sell
3,212
-345
-10% -$38K ﹤0.01% 1015
2020
Q2
$310K Buy
+3,557
New +$273K ﹤0.01% 1209

Other funds holding INSP

ProShare Advisors's INSP Position: Q2 2023 in Review

ProShare Advisors sold out of Inspire Medical Systems (INSP) in Q2 2023, closing a stake of 3,462 shares — an estimated $810K sold.

ProShare Advisors first reported a position in INSP in Q2 2020 and held it in 12 quarters. The position peaked at $1.45M in Q1 2021. 407 funds tracked by Wall St. Rank hold INSP as of Q2 2023.

  • ProShare Advisors reported no remaining Inspire Medical Systems position as of Q2 2023 after selling out during the quarter.
  • ProShare Advisors sold 3,462 Inspire Medical Systems shares in Q2 2023, an estimated $810K.
  • ProShare Advisors first reported a position in Inspire Medical Systems in Q2 2020 and held it in 12 quarters.
  • ProShare Advisors's Inspire Medical Systems position peaked at $1.45M in Q1 2021.
  • 407 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2023.

Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.